CSI Market
Sign In | Register

Scinai Immunotherapeutics Ltd (SCNI) Annual Balance Sheets

Annual · GAAP · USD millions
Access SCNI quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Scinai Immunotherapeutics Ltd's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Assets
Cash & cash equivalent1.66
Cash, Cash Equivalents Other0.00
Cash & Short-term Investments1.00
Accounts receivable0.07
Trade & Other Current Receivables (IFRS combined total)-
Other Receivables0.15
Notes Receivable, Current0.00
Other Current Assets0.15
Prepaid Expense And Other Assets Current0.01
Total Current Assets2.05
Equipment/Property/Plant Net5.88
Long-term investments0.00
Tax Assets, Noncurrent28.11
Deferred, Prepaid and Other Assets, Noncurrent0.08
Other Assets, Noncurrent0.00
Restricted Cash Current0.15
Operating Lease Right Of Use Asset1.78
Total Assets11.63
Liabilities
Accounts Payable0.85
Accrued Liabilities, Current0.44
Financial Instruments0.00
Short-term Debt0.00
Other Liabilities, Current0.74
Deferred Liability and Revenue0.09
Total Current Liabilities1.59
Long-term debt0.29
Total Long-term Debt0.29
Derivative Liability, Noncurrent DE0.00
Accrued Income Taxes, Noncurrent0.41
Other liabilities, Noncurrent0.00
Operating Lease Liability Current0.33
Operating Lease Liability Noncurrent1.64
Total Liabilities2.29
Stockholders' Equity
Additional Paid In Capital Common Stock130.06
Retained Earnings / Accumulated Deficit-125.85
Accumulated Other Comprehensive Income-1.74
Defined Benefit Plan and Other0.00
Other Equity-1.74
Common Stockholder's Equity2.48
Preferred Stockholder's Equity34.00
Total Stockholder's Equity8.10
Liabilities & Stockholder's Equity11.63
4 historic quarters locked

Sign in to unlock the full Scinai Immunotherapeutics Ltd balance sheet history.

Sign In Create Free Account

About Scinai Immunotherapeutics Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-038011

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License